Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Purchases 701,447 Shares of Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 701,447 shares of the stock in a transaction on Wednesday, June 10th. The stock was acquired at an average cost of $0.23 per share, with a total value of $161,332.81. Following the completion of the purchase, the chief executive officer directly owned 13,263,361 shares of the company’s stock, valued at $3,050,573.03. The trade was a 5.58% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link.

Grigorios Siokas also recently made the following trade(s):

• On Thursday, June 11th, Grigorios Siokas purchased 218,447 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.21 per share, with a total value of $45,873.87.

Cosmos Health Stock Performance

Shares of NASDAQ:COSM opened at $0.21 on Friday. The company has a market cap of $13.04 million, a price-to-earnings ratio of -0.33 and a beta of 4.79. The company has a 50-day moving average price of $0.30 and a 200-day moving average price of $0.40. The company has a current ratio of 1.08, a quick ratio of 0.92 and a debt-to-equity ratio of 0.31. Cosmos Health Inc. has a 12 month low of $0.20 and a 12 month high of $1.32.

Cosmos Health (NASDAQ:COSM) last issued its quarterly earnings data on Thursday, May 21st. The company reported ($0.06) EPS for the quarter, meeting the consensus estimate of ($0.06). The firm had revenue of $18.40 million during the quarter, compared to the consensus estimate of $17.93 million. Cosmos Health had a negative net margin of 30.41% and a negative return on equity of 52.85%. As a group, equities analysts anticipate that Cosmos Health Inc. will post -0.06 EPS for the current year.

Cosmos Health News Roundup

Here are the key news stories impacting Cosmos Health this week:

• Positive Sentiment: The company reported annualized sales above $1.5 million for its C-Scrub and C-Sept antiseptic brands in the UK and Greece, and outlined EU expansion plans that could target $7.4 million in revenue and $5.3 million in gross profit by 2028. Article Title
• Positive Sentiment: Cosmos Health announced new contract manufacturing orders totaling 253,657 units, adding to evidence that its Cana subsidiary is seeing steady commercial demand across multiple medicines and pharmaceutical products. Article Title
• Positive Sentiment: CEO Grigorios Siokas made additional open-market share purchases, which investors often view as a signal of management confidence in the company’s outlook. Article Title
• Positive Sentiment: The company signed a letter of intent to acquire Doc Pharma S.A., a GMP manufacturer, a move that could expand assets, production capacity, margins, and its product portfolio if completed. Article Title

Hedge Funds Weigh In On Cosmos Health

Several hedge funds and other institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC raised its stake in shares of Cosmos Health by 16.7% during the first quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock valued at $124,000 after acquiring an additional 55,925 shares during the last quarter. XTX Topco Ltd raised its stake in shares of Cosmos Health by 52.1% during the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after acquiring an additional 34,117 shares during the last quarter. Finally, Citadel Advisors LLC raised its stake in shares of Cosmos Health by 133.1% during the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after acquiring an additional 128,776 shares during the last quarter. 12.61% of the stock is owned by institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.